Al Jazeera: The saga of Merrimack Pharmaceuticals (AMP) and the company that owns it
Al Jazeera’s Al Jazeera Investigations team is investigating the story of the pharmaceutical company Merrimacks.In December 2015, Merrimacs stock was trading at $3.62, an increase of more than 300% over the previous year.The company has since gone on a buyback programme that has seen it acquire stakes in some of the most profitable pharmaceutical companies…